Global Influenza Vaccine Market Research Report 2022

Global Influenza Vaccine Market Research Report 2022

Table of Contents
1 Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Influenza Vaccine
1.2 Influenza Vaccine Segment by Type
1.2.1 Global Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Influenza Vaccine Segment by Application
1.3.1 Global Influenza Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Influenza Vaccine Revenue 2017-2028
1.4.2 Global Influenza Vaccine Sales 2017-2028
1.4.3 Influenza Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Influenza Vaccine Market Competition by Manufacturers
2.1 Global Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Influenza Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Influenza Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Influenza Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Influenza Vaccine Players Market Share by Revenue
2.5.3 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Influenza Vaccine Market Facts & Figures by Country
3.3.1 North America Influenza Vaccine Sales by Country
3.3.2 North America Influenza Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Influenza Vaccine Market Facts & Figures by Country
3.4.1 Europe Influenza Vaccine Sales by Country
3.4.2 Europe Influenza Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Influenza Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Influenza Vaccine Sales by Region
3.5.2 Asia Pacific Influenza Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Influenza Vaccine Market Facts & Figures by Country
3.6.1 Latin America Influenza Vaccine Sales by Country
3.6.2 Latin America Influenza Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Influenza Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Influenza Vaccine Sales by Country
3.7.2 Middle East and Africa Influenza Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Influenza Vaccine Historic Market Analysis by Type
4.1 Global Influenza Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Influenza Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Influenza Vaccine Price by Type (2017-2022)
5 Global Influenza Vaccine Historic Market Analysis by Application
5.1 Global Influenza Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Influenza Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Influenza Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Sanofi Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 CSL Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 GSK Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Viatris Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 AstraZeneca Influenza Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Hualan Bio Influenza Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Changchun Institute of Biological Influenza Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sinovac Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Corporation Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 BCHT Influenza Vaccine Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Corporation Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Jiangsu GDK Influenza Vaccine Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Corporation Information
6.11.2 KM Biologics Influenza Vaccine Description and Business Overview
6.11.3 KM Biologics Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 KM Biologics Influenza Vaccine Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Influenza Vaccine Manufacturing Cost Analysis
7.1 Influenza Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Influenza Vaccine
7.4 Influenza Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Influenza Vaccine Distributors List
8.3 Influenza Vaccine Customers
9 Influenza Vaccine Market Dynamics
9.1 Influenza Vaccine Industry Trends
9.2 Influenza Vaccine Market Drivers
9.3 Influenza Vaccine Market Challenges
9.4 Influenza Vaccine Market Restraints
10 Global Market Forecast
10.1 Influenza Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Influenza Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Influenza Vaccine by Type (2023-2028)
10.2 Influenza Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Influenza Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Influenza Vaccine by Application (2023-2028)
10.3 Influenza Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Influenza Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Influenza Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (M Doses) & (US$ Million)
Table 2. Global Influenza Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (M Doses) & (US$ Million)
Table 3. Global Influenza Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Influenza Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Influenza Vaccine Sales (M Doses) of Key Manufacturers (2017-2022)
Table 6. Global Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Influenza Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Influenza Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Influenza Vaccine Average Price (USD/Doses) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Influenza Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Influenza Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
Table 16. Global Influenza Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Influenza Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
Table 20. North America Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
Table 24. Europe Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
Table 28. Asia Pacific Influenza Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Influenza Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
Table 32. Latin America Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
Table 36. Middle East and Africa Influenza Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Influenza Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
Table 40. Global Influenza Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Influenza Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Influenza Vaccine Price by Type (2017-2022) & (USD/Doses)
Table 44. Global Influenza Vaccine Sales (M Doses) by Application (2017-2022)
Table 45. Global Influenza Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Influenza Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Influenza Vaccine Price by Application (2017-2022) & (USD/Doses)
Table 49. Sanofi Corporation Information
Table 50. Sanofi Description and Business Overview
Table 51. Sanofi Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 52. Sanofi Influenza Vaccine Product
Table 53. Sanofi Recent Developments/Updates
Table 54. CSL Corporation Information
Table 55. CSL Description and Business Overview
Table 56. CSL Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 57. CSL Influenza Vaccine Product
Table 58. CSL Recent Developments/Updates
Table 59. GSK Corporation Information
Table 60. GSK Description and Business Overview
Table 61. GSK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 62. GSK Influenza Vaccine Product
Table 63. GSK Recent Developments/Updates
Table 64. Viatris Corporation Information
Table 65. Viatris Description and Business Overview
Table 66. Viatris Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 67. Viatris Influenza Vaccine Product
Table 68. Viatris Recent Developments/Updates
Table 69. AstraZeneca Corporation Information
Table 70. AstraZeneca Description and Business Overview
Table 71. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 72. AstraZeneca Influenza Vaccine Product
Table 73. AstraZeneca Recent Developments/Updates
Table 74. Hualan Bio Corporation Information
Table 75. Hualan Bio Description and Business Overview
Table 76. Hualan Bio Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 77. Hualan Bio Influenza Vaccine Product
Table 78. Hualan Bio Recent Developments/Updates
Table 79. Changchun Institute of Biological Corporation Information
Table 80. Changchun Institute of Biological Description and Business Overview
Table 81. Changchun Institute of Biological Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 82. Changchun Institute of Biological Influenza Vaccine Product
Table 83. Changchun Institute of Biological Recent Developments/Updates
Table 84. Sinovac Corporation Information
Table 85. Sinovac Description and Business Overview
Table 86. Sinovac Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 87. Sinovac Influenza Vaccine Product
Table 88. Sinovac Recent Developments/Updates
Table 89. BCHT Corporation Information
Table 90. BCHT Description and Business Overview
Table 91. BCHT Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 92. BCHT Influenza Vaccine Product
Table 93. BCHT Recent Developments/Updates
Table 94. Jiangsu GDK Corporation Information
Table 95. Jiangsu GDK Description and Business Overview
Table 96. Jiangsu GDK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 97. Jiangsu GDK Influenza Vaccine Product
Table 98. Jiangsu GDK Recent Developments/Updates
Table 99. KM Biologics Corporation Information
Table 100. KM Biologics Description and Business Overview
Table 101. KM Biologics Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 102. KM Biologics Influenza Vaccine Product
Table 103. KM Biologics Recent Developments/Updates
Table 104. Production Base and Market Concentration Rate of Raw Material
Table 105. Key Suppliers of Raw Materials
Table 106. Influenza Vaccine Distributors List
Table 107. Influenza Vaccine Customers List
Table 108. Influenza Vaccine Market Trends
Table 109. Influenza Vaccine Market Drivers
Table 110. Influenza Vaccine Market Challenges
Table 111. Influenza Vaccine Market Restraints
Table 112. Global Influenza Vaccine Sales Forecast by Type (2023-2028) & (M Doses)
Table 113. Global Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 114. Global Influenza Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 115. Global Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 116. Global Influenza Vaccine Sales Forecast by Application (2023-2028) & (M Doses)
Table 117. Global Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 118. Global Influenza Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 119. Global Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 120. Global Influenza Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
Table 121. Global Influenza Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 122. Global Influenza Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 123. Global Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Influenza Vaccine
Figure 2. Global Influenza Vaccine Market Share by Type in 2021 & 2028
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Global Influenza Vaccine Market Share by Application in 2021 & 2028
Figure 6. 6 Months to 3 Years
Figure 7. > 3 Years
Figure 8. Global Influenza Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Influenza Vaccine Market Size (2017-2028) & (US$ Million)
Figure 10. Global Influenza Vaccine Sales (2017-2028) & (M Doses)
Figure 11. Influenza Vaccine Sales Share by Manufacturers in 2021
Figure 12. Global Influenza Vaccine Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Influenza Vaccine Players: Market Share by Revenue in 2021
Figure 14. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Influenza Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Influenza Vaccine Sales Market Share by Region in 2021
Figure 17. Global Influenza Vaccine Revenue Market Share by Region (2017-2022)
Figure 18. Global Influenza Vaccine Revenue Market Share by Region in 2021
Figure 19. U.S. Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Turkey Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Saudi Arabia Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. UAE Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Sales Market Share of Influenza Vaccine by Type (2017-2022)
Figure 42. Manufacturing Cost Structure of Influenza Vaccine
Figure 43. Manufacturing Process Analysis of Influenza Vaccine
Figure 44. Influenza Vaccine Industrial Chain Analysis
Figure 45. Channels of Distribution
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs